Nl-Fr

Satellite Symposium - Sandoz

View entire schedule
BIOSIMILARS: 20 years of impact in Europe. What’s next in ophthalmology?
Commercial symposium
Wednesday 26 November 2025, 17:30 - 18:30, SILVER (295)

Sessie 1: 
Biosimilars in Ophthalmology: From Regulatory Approval to Market Access in Belgium (ENG).
Elif Car, MSc, PhD Researcher (KU Leuven)

Sessie 2:
Mylight: A Phase 3, pivotal, Multicenter, Randomized, Double-masked, 2-arm Parallel Study to Confirm the Efficacy and Safety of the proposed biosimilar Aflibercept, SDZ-AFL, in Patients With Neovascular Age-related Macular Degeneration (FR)
Sylvia Minh-Huyen-Nghiem Buffet, MD, Centre Ophtalmologique d'Imagerie et de Laser, Paris, France
top ^